Effect of Single Dose of Lidocaine before Removal of Cross-Clamp on Prevention of Ventricular Fibrillation in On-Pump CABG Surgery

Objective: To determine the efficacy of Lidocaine administration before removal of cross-clamp on prevention of Ventricular Fibrillation (VF) in patients who underwent Coronary Artery Bypass Graft (CABG). Study Design: Quasi-experimental study. Place and Duration of Study: Department of Cardiot...

Full description

Bibliographic Details
Main Authors: Rana Nusrat Iqbal, Fakher e Fayyaz, Rashad Siddiqi, Mehwish Naseer, Hana Khurshid, Azib Ali
Format: Article
Language:English
Published: Army Medical College Rawalpindi 2023-12-01
Series:Pakistan Armed Forces Medical Journal
Subjects:
Online Access:https://www.pafmj.org/PAFMJ/article/view/10814
_version_ 1797341009622859776
author Rana Nusrat Iqbal
Fakher e Fayyaz
Rashad Siddiqi
Mehwish Naseer
Hana Khurshid
Azib Ali
author_facet Rana Nusrat Iqbal
Fakher e Fayyaz
Rashad Siddiqi
Mehwish Naseer
Hana Khurshid
Azib Ali
author_sort Rana Nusrat Iqbal
collection DOAJ
description Objective: To determine the efficacy of Lidocaine administration before removal of cross-clamp on prevention of Ventricular Fibrillation (VF) in patients who underwent Coronary Artery Bypass Graft (CABG). Study Design: Quasi-experimental study. Place and Duration of Study: Department of Cardiothoracic Anesthesia, Army Cardiac Center, Lahore Pakistan, from Sep 2021 to Mar 2022. Methodology: One hundred and sixty-two patients were selected non-randomly via consecutive sampling. Patients were divided into two groups i.e., Control and Lidocaine group. Patients of control group were given intravenous Normal Saline while patients in Lidocaine group were given intravenous 2% Lidocaine in dose of 1mg/kg just before release of aortic cross clamp. Main outcome variable was frequency of Ventricular Fibrillation after removal of cross-clamp whereas bypass time, cross-clamp time, Mean Arterial Pressure (MAP) after cardiopulmonary bypass were noted for comparison purpose. Chisquare and t-test were used to compare frequency and mean differences of study variables among study groups. p-value<0.05 was considered statistically significant. Results: One hundred and sixty-two patients with mean age 55.92±6.81 years were recruited. Ventricular Fibrillation (VF) was noted in 43(53.1%) in control group and 11(13.5%) in Lidocaine group (p<0.001). The use of intravenous Lidocaine caused reperfusion VF to occur less frequently which in turn reduced the requirement for electric counter-shock defibrillation. Conclusion: The use of intravenous Lidocaine (1 mg/kg) 2 minutes prior to release of the aortic cross-clamp decreased the frequency of reperfusion Ventricular Fibrillation among subjects who underwent CABG.
first_indexed 2024-03-08T10:11:41Z
format Article
id doaj.art-561abb035ffb426189687d138a722891
institution Directory Open Access Journal
issn 0030-9648
2411-8842
language English
last_indexed 2024-03-08T10:11:41Z
publishDate 2023-12-01
publisher Army Medical College Rawalpindi
record_format Article
series Pakistan Armed Forces Medical Journal
spelling doaj.art-561abb035ffb426189687d138a7228912024-01-29T08:23:27ZengArmy Medical College RawalpindiPakistan Armed Forces Medical Journal0030-96482411-88422023-12-0173SUPPL-310.51253/pafmj.v73iSUPPL-3.10814Effect of Single Dose of Lidocaine before Removal of Cross-Clamp on Prevention of Ventricular Fibrillation in On-Pump CABG SurgeryRana Nusrat Iqbal0Fakher e Fayyaz1Rashad Siddiqi2Mehwish Naseer3Hana Khurshid4Azib Ali5Department of Adult Cardiac Anesthesia, Army Cardiac Center, Lahore PakistanDepartment of Adult Cardiac Anesthesia, Army Cardiac Center, Lahore PakistanDepartment of Adult Cardiac Anesthesia, Army Cardiac Center, Lahore PakistanDepartment of Adult Cardiac Anesthesia, Army Cardiac Center, Lahore PakistanDepartment of Anesthesia, Hameed Latif Hospital, Lahore PakistanDepartment of Adult Cardiac Anesthesia, Army Cardiac Center, Lahore Pakistan Objective: To determine the efficacy of Lidocaine administration before removal of cross-clamp on prevention of Ventricular Fibrillation (VF) in patients who underwent Coronary Artery Bypass Graft (CABG). Study Design: Quasi-experimental study. Place and Duration of Study: Department of Cardiothoracic Anesthesia, Army Cardiac Center, Lahore Pakistan, from Sep 2021 to Mar 2022. Methodology: One hundred and sixty-two patients were selected non-randomly via consecutive sampling. Patients were divided into two groups i.e., Control and Lidocaine group. Patients of control group were given intravenous Normal Saline while patients in Lidocaine group were given intravenous 2% Lidocaine in dose of 1mg/kg just before release of aortic cross clamp. Main outcome variable was frequency of Ventricular Fibrillation after removal of cross-clamp whereas bypass time, cross-clamp time, Mean Arterial Pressure (MAP) after cardiopulmonary bypass were noted for comparison purpose. Chisquare and t-test were used to compare frequency and mean differences of study variables among study groups. p-value<0.05 was considered statistically significant. Results: One hundred and sixty-two patients with mean age 55.92±6.81 years were recruited. Ventricular Fibrillation (VF) was noted in 43(53.1%) in control group and 11(13.5%) in Lidocaine group (p<0.001). The use of intravenous Lidocaine caused reperfusion VF to occur less frequently which in turn reduced the requirement for electric counter-shock defibrillation. Conclusion: The use of intravenous Lidocaine (1 mg/kg) 2 minutes prior to release of the aortic cross-clamp decreased the frequency of reperfusion Ventricular Fibrillation among subjects who underwent CABG. https://www.pafmj.org/PAFMJ/article/view/10814Coronary Artery Bypass GraftCross ClampLidocaineReperfusion Ventricular Fibrillation
spellingShingle Rana Nusrat Iqbal
Fakher e Fayyaz
Rashad Siddiqi
Mehwish Naseer
Hana Khurshid
Azib Ali
Effect of Single Dose of Lidocaine before Removal of Cross-Clamp on Prevention of Ventricular Fibrillation in On-Pump CABG Surgery
Pakistan Armed Forces Medical Journal
Coronary Artery Bypass Graft
Cross Clamp
Lidocaine
Reperfusion Ventricular Fibrillation
title Effect of Single Dose of Lidocaine before Removal of Cross-Clamp on Prevention of Ventricular Fibrillation in On-Pump CABG Surgery
title_full Effect of Single Dose of Lidocaine before Removal of Cross-Clamp on Prevention of Ventricular Fibrillation in On-Pump CABG Surgery
title_fullStr Effect of Single Dose of Lidocaine before Removal of Cross-Clamp on Prevention of Ventricular Fibrillation in On-Pump CABG Surgery
title_full_unstemmed Effect of Single Dose of Lidocaine before Removal of Cross-Clamp on Prevention of Ventricular Fibrillation in On-Pump CABG Surgery
title_short Effect of Single Dose of Lidocaine before Removal of Cross-Clamp on Prevention of Ventricular Fibrillation in On-Pump CABG Surgery
title_sort effect of single dose of lidocaine before removal of cross clamp on prevention of ventricular fibrillation in on pump cabg surgery
topic Coronary Artery Bypass Graft
Cross Clamp
Lidocaine
Reperfusion Ventricular Fibrillation
url https://www.pafmj.org/PAFMJ/article/view/10814
work_keys_str_mv AT rananusratiqbal effectofsingledoseoflidocainebeforeremovalofcrossclamponpreventionofventricularfibrillationinonpumpcabgsurgery
AT fakherefayyaz effectofsingledoseoflidocainebeforeremovalofcrossclamponpreventionofventricularfibrillationinonpumpcabgsurgery
AT rashadsiddiqi effectofsingledoseoflidocainebeforeremovalofcrossclamponpreventionofventricularfibrillationinonpumpcabgsurgery
AT mehwishnaseer effectofsingledoseoflidocainebeforeremovalofcrossclamponpreventionofventricularfibrillationinonpumpcabgsurgery
AT hanakhurshid effectofsingledoseoflidocainebeforeremovalofcrossclamponpreventionofventricularfibrillationinonpumpcabgsurgery
AT azibali effectofsingledoseoflidocainebeforeremovalofcrossclamponpreventionofventricularfibrillationinonpumpcabgsurgery